Abstract: A rimlock for use with an eyeglass frame is provided. The rimlock comprises a pair of flanges which protrude from the frame at a split therein. A spring is fed through a bore passing through the flanges whereby a portion of the spring internal to the rimlock at a widened portion of the bore is in tension thereby biasing the flanges into engagement allowing the frame to hold a lens in position within the frame. By pulling the flanges apart, the lens can be removed.

Abstract: A rimlock for use with an eyeglass frame is provided. The rimlock comprises a pair of flanges which protrude from the frame at a split therein. A spring is fed through a bore passing through the flanges whereby a portion of the spring internal to the rimlock at a widened portion of the bore is in tension thereby biasing the flanges into engagement allowing the frame to hold a lens in position within the frame. By pulling the flanges apart, the lens can be removed.

Abstract: A first method is disclosed for mapping data from a plurality of objects to a relational database. The method begins with the step of generating a transit object and its structure (TO.sub.-- schema, dataGraph and dataBlocks). The next step of the method is populating the transit object based on the data of the plurality of objects. The method continues with the step of transmitting the transit object from the client object broker (COB) to the server object broker (SOB) using a communication server. The method next includes the step of populating a data structure based on the dataBlock object. The method concludes with the step of populating the relation&l database based on the data structure. A second method is also disclosed for mapping data from a relational database to a plurality of objects.

Abstract: Adjustable flow electromagnetic valve having a closing assembly (8) movable within a chamber (7) with a passage (3) linked to a high pressure area and a passage (4) linked to a low pressure area. The electromagnetic valve is designed such that the closing assembly consists of a valve (8) freely movable within the chamber (7). The disk-shaped valve (8) is flat, light and non-deformable and is capable of being automatically brought to its fluid flow position when pressure within the inlet passage (HP) (5) tends to a value approaching a predefined set pressure; the electromagnetic valve is also designed such that fluid flow through the valve (8) is achieved by openings (10) formed in the thickness of the valve, the openings being arranged in a median area outside the circumference of the inlet passage (3) so that the latter can be closed when the valve (8) is electromagnetically returned.

Abstract: A method and system for generating a user interface in a database management system. A semantic data model is used to describe a database in terms of data types stored in the database and functional types that describe relationships between the data types stored in the database. The system dynamically queries the data model to generate a graph of the data model itself. These queries are initiated by the system without user intervention. The user selects a node on the graph that causes the data model to be searched again to determine the name of the node selected, one or more types of relationships associated with the node selected and one or more instances of the relationships associated with the node selected. This information is used to generate a form containing a plurality of blanks. A user enters a query constraint into one or more of the blanks and the database is searched for instances of data meeting the query constraints.

Abstract: The present invention relates to an aerosol composition containing a carrier agent capable of recognizing and binding to inflammatory and tumor foci mobilizing macrophages in their immediate environment, and an aerosol substrate, characterized in that the said carrier agent consists of a polysaccharide compound selected from the compound D 25, extracted from the membrane proteoglycans of the bacterium Klebsiella pneumoniae and having a molecular weight of 30.+-.0.10 Kd, and the compound oxidized D 25 in which the galactofuranoser residue (Gal.sub.f) of the linear polysaccharide chain of D 25 has been converted to arabinose, and their amide, ester or ether type derivatives, as well as their quaternary ammonium derivatives and salts, and also the derivatives obtained by grafting of phosphatides.

Abstract: A measuring circuit for the additive phase noise characteristic of a component in the vicinity of a carrier frequency. The measuring circuit is constructed of a central channel and two side channels. Each of these channels contains a model of the component to be characterized. Two phase detecting circuits are employed in which each processes an input signal from one of the side channels with an input signal from the central channel to generate signals which represent phase deviations between the two input signals. An intercorrelation circuit then utilizes the outputs from these phase detecting circuits to determine the characteristic additive phase noise of the component to be characterized by eliminating any additive phase noise superadded by other measuring circuit elements or induced by outside disturbances.

Abstract: A packaging pot for marketing various products, comprising a container housed within a casing body covered by a casing lid which pivots about a horizontal articulation, with a resilient snap-action closure system releasable by manual action on an externally projecting lug. The container is clamped in a single-piece ring comprising a lower annular member which is integral with the container and a pivoting upper annular member which is joined to the lower annular member by means of a flexible hinge-strap, the two annular members being provided respectively with complementary snap-fastening elements, the top portion of the casing body being fastened around the lower annular member and the bottom portion of the casing lid being fastened around the upper annular member.

Abstract: The present invention relates to a vaccinal complex containing a specific antigen. This is a vaccinal complex characterized in that it is composed of bacterial ribosomal RNA or fragments of bacterial ribosomal RNA on which are coupled from 1 to 5% by weight of a specific antigen of bacterial serotype. This complex may be used as a vaccine.

Abstract: This invention relates to a process for the preparation of purified bacterial membranal proteoglycans. The process comprises at least one step in which crude proteoglycans are treated in aqueous medium with a base or a hypobromite, followed by elimination of the excess reactant and the insoluble residue, the purified proteoglycans being present in aqueous solution. The thus obtained purified proteoglycans may be used as immunity adjuvants in vaccines without causing side-effects such as pyrogenic reactions.

Abstract: This invention relates to a non-specific immunostimulating preparation for the treatment of immunodeficits, such as those encountered in leprosy and cancer, characterized in that it contains as sole active principle one or more bacterial ribosomal RNA's extracted from the following strains:Klebsiella pneumoniaeSerratia marcescens

Abstract: This invention relates to a process for the preparation of purified bacterial membranal proteoglycans. The process comprises at least one step in which crude proteoglycans are treated in aqueous medium with a base or a hypobromite, followed by elimination of the excess reactant and the insoluble residue, the purified proteoglycans being present in aqueous solution. The thus obtained purified proteoglycans may be used as immunity adjuvants in vaccines without causing side-effects such as pyrogenic reactions.

Abstract: The present invention relates to a pharmaceutical composition comprising a plasminogen activator and a polysaccharide sulphate. The invention also covers a process for preparing the pharmaceutical composition and a process for preparing the plasminogen activator.The pharmaceutical compositions are useful in the treatment of circulatory disorders such as venous thromboses.

Abstract: A process for obtaining a plasminogen activator involves treating an acetone extract powder of organs of animals, such as the lungs and kidneys of pigs, calves, bullocks, horses, lambs or sheep or the ovaries of porcine, bovine or ovine animals, by suspension in an aqueous saline solution, taking up the precipitate obtained in an aqueous saline solution of greater ionic strength and lower pH-value, decanting the solution and precipitating therefrom at acidic pH by adding a salt or an organic solvent, further taking up the precipitate obtained in water or a saline solution, followed by repeated precipitation by adding a salt at a somewhat higher pH-value, finally taking up the precipitate obtained in water and dialyzing the solution, and optionally purifying the solution obtained.The activator obtained may be used as a medicament.